STAT
OCTOBER 26, 2023
Chimpanzees — they’re just like us. Female chimps, it turns out, go through menopause, and go on to live long (and, one hopes, fulfilling) lives afterward. A new paper published today in Science describes the discovery of the onset of menopause in a community of wild chimpanzees around the age of 50, with an overall decline in fertility starting at age 30.
ALiEM - Pharm Pearls
OCTOBER 26, 2023
The Problem: Emergency Medicine (EM) in Pakistan has moved from developing to developed stage in the last decade [1]. As the specialty evolves in Pakistan and other countries, there is a need to improve and assimilate novel learning methods to elevate education standards. The COVID-19 pandemic catalyzed the routine use of video-conference platforms such as Zoom.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 26, 2023
Long hours and high-pressure situations have long characterized the health care profession — but in the wake of the pandemic, many workers are facing new challenges with regards to their mental health. Health care workers are facing a mental health crisis, struggling with burnout, anxiety, and depression, according to a Centers of Disease Control and Prevention report published Tuesday.
PharmaVoice
OCTOBER 26, 2023
On a roll with promising data, the commercial-stage biotech is leveraging drug-Fc conjugates to aim a new weapon at viral targets.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
OCTOBER 26, 2023
History was made this month as more than 75,000 workers staged the largest health care strike to ever take place in the United States. The Kaiser strike is over, for now, but there is no clear resolution in place, and other strikes are still under way or on the horizon. At the same time, we are in the midst of a nurse staffing crisis. About 800,000 nurses plan to leave the workforce by 2027, and more than half of newly graduated nurses are leaving the profession within two years.
EMCrit Project
OCTOBER 26, 2023
Some folks on twitter asked my thoughts on AMIKINHAL trial, so I thought I'd jot them here. AMIKINHAL is a multi-center RCT that evaluated the ability of inhaled amikacin to prevent VAP (ventilator-associated pneumonia) among patients who had been intubated for three days. It's available here at NEJM. It was a positive trial, which is […] EMCrit Project by Josh Farkas.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
BioPharma Dive
OCTOBER 26, 2023
Executives at the biotech say they’re trying to get ahead of the payer and production challenges that will face their gene editing treatment exa-cel, which is now under FDA review.
STAT
OCTOBER 26, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, all. Damian here with a glimpse at the next big thing in Alzheimer’s disease, Pfizer’s future in treating obesity, and the downstream effects of a biotech slump.
The Pharmacist
OCTOBER 26, 2023
Pharmacy bodies have called for 2024/25 winter vaccination programme planning to include key parties such as community pharmacy ‘at an appropriately early stage’. Community Pharmacy England (CPE) and the Royal Pharmaceutical Society (RPS) have joined the NHS Confederation, the Healthcare Distribution Association, vaccine provider CSL Seqirus and the Dispensing Doctors’ Association in writing to the […] The post Include community pharmacy in early vaccination planning, sector demands appear
STAT
OCTOBER 26, 2023
How do cancer drugs work? What makes biotech stocks go up? And why are venture capitalists so optimistic? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Andrew Joseph joins us to explain the decades-old cancer-treating technology that had its star turn at this week’s big oncology conference in Europe.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Times
OCTOBER 26, 2023
Thousands of patients with heart failure are set to benefit from the expansion - News - PharmaTimes
STAT
OCTOBER 26, 2023
Hello, everyone, and how are you this morning? We are doing just fine, thank you, as we muddle along, trying to organize our to-do list and set our priorities. There is an intensity to such mundane tasks, though, that calls for a cup of stimulation. So as we fire up the coffee kettle today, we are reaching for Vermont maple walnut. As always, you are invited to join us.
Digital Pharmacist
OCTOBER 26, 2023
In recent weeks, the pharmacy industry has been shaken up as staff walkouts at CVS and Walgreens captured the attention of pharmacy teams and patients alike. These walkouts have left many curious about the reasons behind them and what implications these events may have on the future of the pharmacy profession. By understanding what led retail pharmacy team members to take these drastic actions, we can look at what independent pharmacies can do to avoid similar issues and also how independents ca
STAT
OCTOBER 26, 2023
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Teladoc’s stock slides despite business growth Teladoc Health on Tuesday reported solid third quarter earnings showing $660 million in revenue for 8% year-over-year growth and improvement across business lines including BetterHelp and its
PharmExec
OCTOBER 26, 2023
A discussion of the biggest digital trends in clinical research, how COVID-19 impacted digital use for sponsors/CROs, what the future of DCT services looks like, and more.
Pharma Times
OCTOBER 26, 2023
The two projects will be awarded $1m each to support their clinical investigations - News - PharmaTimes
European Pharmaceutical Review
OCTOBER 26, 2023
Antibody-drug conjugates (ADCs), such as datopotamab deruxtecan (Dato-DXd) and trastuzumab deruxtecan, have demonstrated compelling evidence of efficacy in oncology across numerous diseases in recent months. In August 2023, Biswajit Podder, PhD, Oncology and Hematology Analyst at GlobalData shared that HER2-positive breast cancer “seems to be a major focus” in ADC drug development.
Express Pharma
OCTOBER 26, 2023
Venus Remedies has received market authorisation in the UK for Bleomycin 15,000 IU powder for solution for injection/infusion by its German subsidiary, Venus Pharma GmbH. Bleomycin 15,000 IU is a potent medication that contains the active ingredient bleomycin sulfate. It belongs to a group of medicines known as cytostatic drugs, specifically designed to combat cancer.
BioPharma Dive
OCTOBER 26, 2023
The partners announced the trial had succeeded weeks after Moderna disclosed positive results from a study of its similar combination vaccine.
Pharmaceutical Commerce
OCTOBER 26, 2023
How setting action-based goals and cultivating partnerships will help overcome challenges associated with implementing a sustainable GHG strategy.
Pharmaceutical Technology
OCTOBER 26, 2023
The potential for using gene therapies to treat sickle cell disease is high, but their durability and high price point invite scrutiny.
PharmaTech
OCTOBER 26, 2023
The treatment has received Priority Review designation, as well as FDA Breakthrough Therapy designation and Orphan Drug designation.
Pharmaceutical Technology
OCTOBER 26, 2023
The EC announced new initiatives to tackle critical medicine shortages in winter, introducing more flexibility to strengthen supplies.
The Script
OCTOBER 26, 2023
Have you ever been interested in becoming a pharmacy tech? Our team at Rx relief dives deep into the career.
Pharmaceutical Technology
OCTOBER 26, 2023
A pivotal Phase III trial will be initiated in the coming months to further evaluate the lead formulations of the combination vaccine.
BioPharma Dive
OCTOBER 26, 2023
“Data is king and it’s something that is really standing true in this market,” said William Blair’s Kevin Eisele in one of two panels hosted Wednesday by BioPharma Dive.
Outsourcing Pharma
OCTOBER 26, 2023
A company that says they have never had a client say they have started their data work too soon has launched a âbold data first strategyâ.
pharmaphorum
OCTOBER 26, 2023
COVID, flu combo jab from Pfizer/BioNTech heads for phase 3 Phil.
Outsourcing Pharma
OCTOBER 26, 2023
At the end of the first successful day at CPHI Barcelona, 2023, an awards ceremony was held to announce the winners of the CPHI Pharma Awards.
European Pharmaceutical Review
OCTOBER 26, 2023
The National Institute for Health and Care Excellence (NICE) has recommended AbbVie’s foslevodopa–foscarbidopa (Produodopa) as a treatment option for advanced Parkinson’s. The treatment is administered by an infusion pump over 24 hours. A benefit of the device is its small size, in addition to its portability and the fact it can be refilled at home.
pharmaphorum
OCTOBER 26, 2023
The longitudinal history of medicines innovation: Part One Mike.
BioPharma Dive
OCTOBER 26, 2023
Backed by like Atlas, Cormorant and OrbiMed, Triveni is developing an antibody drug for eczema and asthma that takes aim at a different kind of target.
World Pharma News
OCTOBER 26, 2023
Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ. This finding raises potential concerns about quality of care, and the researchers say it may be appropriate to re-examine the current status of personal payments from the drug industry to physicians.
pharmaphorum
OCTOBER 26, 2023
How to leverage real-world data for better patient care Mike.
Drug Patent Watch
OCTOBER 26, 2023
Sugammadex sodium is the generic ingredient in two branded drugs marketed by Msd Sub Merck, Aspiro, Mylan, and Sandoz and, and is included in four NDAs. There is one patent… The post New tentative approval for Sandoz drug sugammadex sodium appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
357 
Let's personalize your content